Researchers discuss vaccine development, continued efforts on novel coronavirus

This week, a vaccine candidate for the novel coronavirus hit a new milestone and entered the second phase of clinical trials. But what does that mean in terms of how soon this vaccine — or others — might be ready for public use? 

This vaccine is far from the only trial under way, with researchers around the world racing to safely produce a product — or products — to protect against COVID-19 infection.

Join Kerri Miller on our weekly show focusing on the science of the novel coronavirus as she talks with two researchers about how the vaccine development process works and the speed of the science happening during a pandemic. We’ll also answer your questions.

Guests:

• Deborah Fuller is vaccine expert and professor of microbiology at the University of Washington School of Medicine.

• Angela Rasmussen is a virologist and associate research scientist at Columbia University’s Mailman School of Public Health.

To listen to the full conversation you can use the audio player above.

Subscribe to the MPR News with Kerri Miller podcast on: Apple Podcasts, Google Podcasts , Spotify or RSS